Articles about Pfizer
20 Sep 2021
Pfizer-BioNTech vaccine 'safe' for kids aged 5-11; generates 'robust immunity'
The COVID-19 vaccine developed by Pfizer and BioNTech has been found safe for children ages 5 to 11 years old and generates a "robust" immune response, the companies said Monday.
14 Sep 2021
England school children aged 12-15yrs to be offered COVID-19 vaccine
School children aged between 12 and 15 years will be offered a first dose of the Pfizer/BioNTech COVID-19 vaccine starting next week, the UK government has announced after the country's Chief Medical Officers gave their go-ahead for the jabs for younger age groups.
13 Sep 2021
COVID-19 vaccines for younger kids could be available from October
Amid surging Delta variant cases in the USA, COVID-19 vaccines for children younger than 12 years could be available by the end of next month, a media report has said.
09 Sep 2021
No serious vaccine side effects in breastfeeding moms, infants: Study
Breastfeeding mothers vaccinated with Pfizer or Moderna preventive experienced similar side effects to what have previously been reported in non-breastfeeding women, while infants exhibited no adverse events after immunization, a study has found.
06 Sep 2021
80% immunity from Pfizer vaccine lost in 6 months: Study
COVID-19 antibodies generated by the Pfizer vaccine dipped by more than 80% six months after the second dose, a study conducted in the United States has found.
23 Aug 2021
US: Pfizer-BioNTech COVID-19 vaccine officially granted full approval by FDA
The Pfizer-BioNTech COVID-19 vaccine has finally received full approval from the US Food and Drug Administration (FDA) on Monday for use in people aged 16 and above in the country.
21 Aug 2021
Pfizer-BioNTech COVID-19 vaccine to get US-FDA's full approval next week
The United States Food and Drug Administration (FDA) is reportedly set to grant full approval to Pfizer-BioNTech's two-dose COVID-19 vaccine next week, expediting the previous timeline for licensing the vaccine.
19 Aug 2021
Pfizer, AstraZeneca vaccines less effective against Delta variant: Oxford study
COVID-19 vaccines developed by Pfizer and AstraZeneca are less effective against the Delta variant of the coronavirus, compared to the Alpha variant, a study led by researchers at the University of Oxford said.
20 Jul 2021
No sign of Pfizer, Moderna vaccines in breast milk: Study
Researchers have found no evidence of the presence of Pfizer or Moderna COVID-19 vaccines in breast milk suggesting that mRNA preventives are safe during lactation.
05 Jul 2021
Pfizer COVID-19 vaccine induces good immune response against coronavirus variants
Two doses of the Pfizer COVID-19 vaccine induce a "very good" antibody response against the SARS-CoV-2 variants, according to a study on 180 health care workers in Finland.
02 Jul 2021
Mix-and-match COVID-19 vaccines: What do studies say?
In most coronavirus vaccination regimes, two doses of the same brand are given a few weeks apart.
24 Jun 2021
Single dose of Pfizer, AstraZeneca vaccines offers 60 percent protection
A single dose of Pfizer or AstraZeneca COVID-19 vaccine offers around 60 percent protection against infection from SARS-CoV-2 in adults aged 65 years and above, according to a study published in The Lancet Infectious Diseases.
15 Jun 2021
Pfizer, AstraZeneca vaccines protect against Delta variant, says study
Pfizer and AstraZeneca vaccines provide good protection against the Delta variant of coronavirus, first identified in India, says a study published in The Lancet Journal.
14 Jun 2021
How does India plan to vaccinate children against coronavirus?
The Indian government wants to soon start inoculating children against the coronavirus. However, there is no vaccine for that group yet.
10 Jun 2021
US will distribute 500M Pfizer vaccine doses to 100 countries
The United States is buying 500 million doses of the Pfizer coronavirus vaccine to donate them among nearly 100 countries by the next year, top American newspapers have reported.
10 Jun 2021
When will the COVID-19 vaccine for children be ready?
India does not have a coronavirus vaccine for children as yet.
04 Jun 2021
'Benefits outweigh risks'; UK clears Pfizer vaccine for ages 12-15
The United Kingdom on Friday decided to approve the COVID-19 vaccine developed by Pfizer-BioNTech for use among those aged 12-15 years.
03 Jun 2021
After Pfizer and Moderna, Serum seeks indemnity over COVID-19 vaccine
The Serum Institute of India has requested the Indian government to provide it indemnity from liability in connection with its COVID-19 vaccines, company sources cited by NDTV and The Hindu say.
03 Jun 2021
Most COVID-19 vaccines might offer lasting protection: Study
The world's leading COVID-19 vaccines, including the ones from Pfizer and Moderna, may offer lasting protection that diminishes the need for frequent booster shots.
02 Jun 2021
Israel finds possible link between Pfizer vaccine and heart inflammation
Israel has flagged a possible link between the COVID-19 vaccine developed by Pfizer-BioNTech and cases of heart inflammation (myocarditis), observed mainly in young men.
02 Jun 2021
Foreign COVID-19 vaccines exempted from local trials, batch testing
The Drugs Controller General of India has scrapped the requirement of local trials for foreign-made coronavirus vaccines - a key move to upscale the dwindling COVID-19 vaccinations in the country.
27 May 2021
India should procure Pfizer's COVID-19 vaccine for children: Kejriwal
Delhi Chief Minister Arvind Kejriwal on Thursday sought procurement of Pfizer COVID-19 vaccine as soon as possible to inoculate children.
27 May 2021
Pfizer's vaccine works against B.1.617 variant, firm tells Indian government
Pfizer has told the Indian government that its coronavirus vaccine shows "high effectiveness" on the COVID-19 variant prevalent in India as well as on people of Indian ethnicity or nationality.
25 May 2021
India may not receive Pfizer, Moderna vaccine doses until 2023
India may not receive doses of the COVID-19 vaccines developed by Pfizer and Moderna until 2023 as the manufacturers have other commitments.
24 May 2021
Pfizer, Moderna have refused to sell vaccines directly to Delhi
American pharmaceutical companies Pfizer and Moderna have said they would not sell their coronavirus vaccines directly to the Delhi government, Chief Minister Arvind Kejriwal revealed today.
21 May 2021
Delayed second Pfizer shot boosts immunity by over three times
Delay in giving a second dose of the Pfizer COVID-19 vaccine by 12 weeks increases antibody response in older people by three-and-a-half times compared to those who receive it at a three-week interval, according to a study conducted in the UK.
15 May 2021
India may buy 50mn Pfizer COVID-19 vaccine doses: Details here
At a time when India is facing an acute shortage of COVID-19 vaccines, the Centre is in "high-level" discussions with American pharmaceutical giant Pfizer, which is likely to sell 50 million doses of its vaccine in India by the third quarter of this year.
14 May 2021
Americans can finally ditch the mask, says CDC
In the biggest indication that the United States is fast returning to pre-pandemic life, the Centers for Disease Control and Prevention (CDC) has said fully vaccinated people are no longer required to wear masks.
11 May 2021
AstraZeneca vaccine's single dose reduces death risk by 80%: Data
A single dose of AstraZeneca's COVID-19 vaccine results in an 80% less risk of death from the viral infection, Public Health England (PHE), the executive agency of the UK department of health, said on Monday, citing data from the vaccine's rollout.
11 May 2021
US expands Pfizer COVID-19 shot to children 12 and above
COVID-19 vaccines finally are headed for more kids as US regulators on Monday expanded the use of Pfizer's shot to those as young as 12, sparking a race to protect middle and high school students before they head back to class.
03 May 2021
Pfizer in talks with India for expedited approval for vaccine
United States pharmaceutical major Pfizer is in talks with the Indian government to seek expedited approval for its COVID-19 vaccine.
22 Apr 2021
Pfizer will supply COVID-19 vaccine only through government channels
Pharmaceutical giant Pfizer will supply its coronavirus vaccine only through government channels in India, The Indian Express reported today.
30 Mar 2021
Pfizer, Moderna's coronavirus vaccines effective even after first dose: Study
The coronavirus vaccines developed by American pharma giant Pfizer, with Germany's BioNTech, and the one manufactured by Moderna, another United States company, reduce the risk of infection even after the first dose, a study has found, reports Reuters.
26 Mar 2021
Pfizer-BioNTech's coronavirus vaccine being tested on children under 12
American pharma giant Pfizer and German company BioNTech began testing their coronavirus vaccine on children, aged under 12, reports Reuters.
24 Mar 2021
Hong Kong suspends Pfizer vaccines over packaging defects
Hong Kong suspended vaccinations using Pfizer-BioNTech COVID-19 shots in the city on Wednesday after they were informed by its distributor Fosun that one batch had defective bottle lids.
17 Feb 2021
Pfizer-BioNTech to give EU another 200 million COVID-19 shots
Pfizer and BioNTech, on Wednesday, finalized an agreement to supply the European Union with another 200 million doses of their COVID-19 vaccine.
05 Feb 2021
Expert panel recommended against granting EUA to Pfizer's vaccine: Officials
Just two days before pharma major Pfizer announced the withdrawal of its application for emergency use authorization of its COVID-19 vaccine in India, an expert panel of the country's drugs regulatory authority had recommended against granting such approval to the firm at this stage.
04 Feb 2021
UK begins world's first alternate dosing COVID-19 vaccine trial
Health chiefs in the UK on Thursday began what they have described as the world's first clinical trial of patients who will receive different COVID-19 vaccines for their first or second dose, to detect its impact on immunity against coronavirus.
04 Feb 2021
Recovered COVID-19 patients need only one shot of mRNA vaccines
People who have recovered from COVID-19 may need only one shot as opposed to the recommended two jabs if they are taking the Moderna or Pfizer vaccines, according to a study that suggests ways to minimize doses when supplies are limited.
03 Feb 2021
Russia's coronavirus vaccine approved for use in Mexico
Mexico approved the Russian coronavirus vaccine Sputnik V for use on Tuesday, just hours after the publication of early results of an advanced study saying it is about 91 percent effective.